PATENT CLAIM ANALYSIS

Application Number: 16288374
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "006500"]

Abstract:
The present invention relates to a certain DPP-4 inhibitor for use in cardio- and/or renoprotective therapy, including in patients at high vascular risk.

Claim (Index 18):
The method of  claim 1 , wherein the patient is a type 2 diabetes patient who is na\u00efve or pre-treated with one or more antidiabetic agents, and wherein (a) said patient exhibits insufficient glycemic control by diet and exercise alone, or (b) said patient exhibits insufficient glycemic control by diet and exercise plus despite therapy with one or more antidiabetic agents.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 99.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15616974', '14928048', '15354053', '14633489', '13295174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7581498328446868
- 35 USC 102 Novelty (BERT): 0.6096298942868732
- Combined Prediction Score: 0.7432978389889054
- Mean Citation Score: 402.637482
- Max Citation Score: 575.4381
- Similarity Product: 475.6534722157717

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test